Analogic (Peabody, Massachusetts), an OEM supplier of radio frequency amplifiers for MRI systems, reported completing its previously disclosed acquisition of Copley Controls (Canton, Massachusetts), a supplier of gradient amplifiers for MRI and precision motion control systems used in computer-controlled automation systems. Copley is now a wholly owned subsidiary of Analogic. Analogic paid $76.875 million in cash for Copley, representing the agreed purchase price of $68.75 million plus an adjustment of $8.125 million.

BioHorizons (Birmingham, Alabama) completed its purchase of Implant Logic Systems (ILS, Cedarhurst, New York), first disclosed in January. Terms were not disclosed. ILS will operate as a BioHorizons subsidiary. ILS is a provider for the implant dentistry market. BioHorizons, a dentistry implant company, was founded in 1994 out of an incubator at the University of Alabama-Birmingham. The company was bought by HealthpointCapital (New York) in 2006.

Boston Scientific (Natick, Massachusetts) said that it plans to acquire CryoCor (San Diego), a maker of disposable catheter systems for treating cardiac arrhythmias, to bolster its offerings in the atrial fibrillation (AF) market. Boston Scientific will pay $17.6 million in cash for CryoCor, or about $1.35 a share. This acquisition follows on the heels of a development agreement between the two companies, in place since June 2007, to pursue therapeutic solutions for AF. The existing agreement involves the development of a console to deliver cryo-energy to Boston Scientific's cryo-balloon catheter. The company's cryo-balloon is being developed to provide a standardized and broadly applicable method to isolate the electrical activity originating from the pulmonary veins, which are believed to be a source for the initiation and propagation of AF.

Covidien (Hamilton, Bermuda) reported that it had completed the previously disclosed sale of its Retail Products business in King of Prussia, Pennsylvania, to an affiliate of First Quality Enterprises (Great Neck, New York) for $330 million in cash. Covidien said that the sale of the retail products unit is part of its strategy to focus its portfolio and reallocate resources to its core healthcare business. The company said this strategy also includes the previously reported agreement to sell its European Incontinence business, as well as to divest its Specialty Chemicals business.

Diomed Holdings (Andover, Massachusetts), developer of the EVLT laser treatment for varicose veins, reported that it has entered into an asset purchase agreement with AngioDynamics (Queensbury, New York) for the sale of Diomed's U.S. operations for $8 million in cash. The assets subject to the agreement exclude the proceeds of Diomed's settlement of its '777 patent litigation with AngioDynamics, under which AngioDynamics agreed to pay $7 million, and the proceeds of Diomed's anticipated $3.6 million settlement with Vascular Solutions (Minneapolis) now pending bankruptcy court approval, as well as certain patents. Diomed filed an action against AngioDynamics and Vascular Solutions in March 2004. AngioDynamics has also agreed to pay $3 million in cash for certain of the assets of Diomed Ltd, the UK subsidiary of Diomed, which filed for insolvency administration under the laws of the UK with Diomed's bankruptcy filing in the U.S. Diomed will use its existing cash, receivables and ongoing revenues to fund its operations while it operates under Chapter 11, and, if necessary, may include up to $1.3 million in debtor-in-possession financing from AngioDynamics.

Kinetic Concepts (KCI; San Antonio) reported initiating a tender offer for all outstanding common stock of LifeCell (Branchburg, New Jersey) at $51 a share. In early April KCI reported that it would acquire Lifecell, a maker of tissue-repair products for use in reconstructive, urogynecologic and orthopedic surgical procedures, for about $1.7 billion in cash. The offer is scheduled to expire at midnight, EST, May 16, unless it is extended.

Natus Medical (San Carlos, California) said it has agreed to acquire SonaMed (Waltham, Massachusetts), a private company that makes the Clarity Screener and associated disposable supplies to help medical practitioners screen newborns for hearing loss. Natus has agreed to acquire all outstanding shares of SonaMed capital stock in a cash transaction, however financial terms of the deal were not disclosed. The boards of both companies have approved the acquisition, expected to close in roughly 40 days.

Opto Circuits (Bangalore, India) reported that it has completed its $68 million acquisition of Criticare Systems (Waukesha, Wisconsin). Opto previously had acquired about 92.8% of the common stock of Criticare for $5.50 a share in cash, without interest. Opto develops digital thermometers, sensors, probes, pulse oximeters, patient monitoring systems, cardiac stents and catheters. Criticare makes monitoring systems and noninvasive sensors for a range of hospitals and other healthcare environments.